COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country
(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on July 8, 2021)
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.
For specific updates concerning China and related business advisory, please click here.
Please refresh the page to get the latest updates.
ASEAN coronavirus updates (Live updates by country)
Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.
- Brunei recorded four new cases on July 6, taking the total to 266 cases amid three deaths.
- Brunei saw one new case on July 2, taking the total to 262 cases amid three deaths.
- Brunei reported one new case on July 1, taking the total to 261 cases amid three deaths.
Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.
- Cambodia recorded 954 new cases and 27 deaths on July 8, taking the tallies to 58,057 cases and 825 deaths.
- Cambodia reported 981 new cases and 798 deaths on July 7, taking the totals to 57,103 cases and 798 deaths.
- Cambodia recorded 935 new cases and 31 deaths on July 6, bringing the tallies to 56,122 cases and 779 deaths.
Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 268 million and price sensitivity at Sinovac’s estimated costs at 200,000 rupiah (US$20) a dose. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population. Australia has stated it will also provide financial support to solve these issues.
- Indonesia saw 38,391 new cases and 852 deaths on July 8, taking the tallies to 2,417,788 cases and 63,760 deaths.
- Indonesia recorded 34,379 new cases and 1,040 deaths on July 7, bringing the totals to 2,379,397 cases and 62,908 deaths.
- Indonesia saw 31,189 new cases and 728 deaths on July 6, taking the tallies to 2,345,018 cases and 61,868 deaths.
Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.
- Laos saw 69 new cases on July 8, taking the total to 2,469 cases amid three deaths.
- Laos recorded 44 new cases on July 7, taking the total to 2,400 cases amid three deaths.
- Laos reported 56 new cases on July 6, bringing the total to 2,356 cases amid three deaths.
Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens.
- Malaysia reported 8,868 new cases and 135 deaths on July 8, bringing the tallies to 808,658 cases and 5,903 deaths.
- Malaysia saw 7,097 new cases and 91 deaths on July 7, taking the totals to 799,790 cases and 5,768 deaths.
- Malaysia reported 7,654 new cases and 103 deaths on July 6, bringing the tallies to 792,693 cases and 5,677 deaths.
Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.
- Myanmar saw 3,947 new cases and 57 deaths on July 7, taking the tallies to 175,923 cases and 3,570 deaths.
- Myanmar recorded 3,602 new cases and 52 deaths on July 6, bringing the totals to 171,976 cases and 3,513 deaths.
- Myanmar saw 2,969 new cases and 42 deaths on July 5, taking the tallies to 168,374 cases and 3,461 deaths.
The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees.
- The Philippines saw 5,484 new cases and 191 deaths on July 8, taking the totals to 1,455,585 cases and 25,650 deaths.
- The Philippines reported 4,289 new cases and 164 deaths on July 7, taking the tallies to 1,450,110 cases and 25,459 deaths.
- The Philippines reported 4,114 new cases and 104 deaths on July 6, bringing the totals to 1,445,832 cases and 25,296 deaths.
Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.
- Singapore saw 16 new cases on July 8, bringing the total to 62,668 cases amid 36 deaths.
- Singapore saw 12 new cases on July 7, taking the total to 62,652 cases amid 36 deaths.
- Singapore recorded 10 new cases on July 6, bringing the total to 62,640 cases amid 36 deaths.
Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.
- Thailand saw 7,058 new cases and 75 deaths on July 8, bringing the totals to 308,230 cases and 2,462 deaths.
- Thailand recorded 6,519 new cases and 54 deaths on July 7, taking the tallies to 301,172 cases and 2,387 deaths.
- Thailand reported 5,420 new cases and 57 deaths on July 6, bringing the totals to 294,653 cases and 2,333 deaths.
Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.
Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.
As of July 8, 2021, Vietnam’s Ministry of Health confirmed a total of 23,385 cases of COVID-19. However, 8,557 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 102 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City and Binh Duong.
As of July 7, 2021, Vietnam’s Ministry of Health confirmed a total of 22,341 cases of COVID-19. However, 8,077 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 102 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Phu Yen, Dong Nai, Ba Ria-Vung Tau, and Ha Tinh.
As of July 6, 2021, Vietnam’s Ministry of Health confirmed a total of 21,312 cases of COVID-19. However, 8,022 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 97 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Phu Yen, Dong Nai, An Giang, and Hung Yen among others.
Other Asian countries and Regions
Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either.
- Afghanistan has 130,113 cases and 5,477 deaths as of July 7.
- As of July 6, Afghanistan has 129,021 cases and 5,415 deaths.
- Afghanistan has 127,464 cases and 5,360 deaths as of July 5.
Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.
- Bangladesh has 989,219 cases and 15,792 deaths as of July 8.
- As of July 7, Bangladesh has 977,568 cases and 15,593 deaths.
- Bangladesh has 966,406 cases and 15,392 deaths as of July 6.
Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.
- Bahrain has 266,797 cases and 1,367 deaths as of July 7.
- Bahrain has 266,685 cases and 1,366 deaths as of July 6.
- As of July 5, Bahrain has 266,557 cases and 1,363 deaths.
For specific updates concerning China, please click here.
For a complete overview of China’s vaccine availability please go here.
- China recorded 17 new cases on July 8, taking the total to 91,966.
- China reported 57 new cases on July 7, taking the total to 91,949.
- China reported 23 new cases on July 6, taking the total to 91,892.
East Timor is receiving assistance from the Gavi Institute.
- As of July 8, East Timor has 9,657 cases and 25 deaths.
- As of July 7, East Timor has 9,594 cases and 25 deaths.
- East Timor has 9,558 cases and 25 deaths as of July 6.
Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.
- Hong Kong has 11,949 cases and 212 deaths as of July 8.
- As of July 7, Hong Kong has 11,946 cases and 212 deaths.
- As of July 6, Hong Kong has 11,945 cases and 212 deaths.
For a complete overview of India’s vaccine availability please go here.
- As of July 7, India has 30,708,570 cases and 405,057 deaths.
- India has 30,662,896 cases and 404,240 deaths as of July 6.
- Our new India-specific updates can be found here.
Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.
- As of July 8, Iran has 3,327,526 cases and 85,397 deaths.
- As of July 7, Iran has 3,304,135 cases and 85,261 deaths.
- Iran has 3,286,923 cases and 85,095 deaths as of July 6.
Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021.
- As of July 7, Iraq has 1,397,100 cases and 17,413 deaths.
- Iraq has 1,388,323 cases and 17,376 deaths as of July 6.
- As of July 5, Iraq has 1,379,505 cases and 17,345 deaths.
Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021.
- As of July 8, Japan has 811,712 cases and 14,897 deaths.
- Japan has 809,553 cases and 14,884 deaths as of July 7.
- As of July 6, Japan has 807,951 cases and 14,862 deaths.
Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021.
- Jordan has 754,927 cases and 9,800 deaths as of July 7.
- As of July 6, Jordan has 754,281 cases and 9,795 deaths.
- Jordan has 753,776 cases and 9,785 deaths as of July 5.
Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.
- Kazakhstan has 445,091 cases and 4,544 deaths as of July 8.
- As of July 7, Kazakhstan has 442,291 cases and 4,516 deaths.
- As of July 6, Kazakhstan has 439,580 cases and 4,489 deaths.
All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.
- As of July 7, Kuwait has 369,227 cases and 2,059 deaths.
- Kuwait has 367,642 cases and 2,049 deaths as of July 6.
- Kuwait has 365,649 cases and 2,029 deaths as of July 5.
Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021.
- Kyrgyzstan has 135,739 cases and 2,073 deaths as of July 8.
- As of July 7, Kyrgyzstan has 134,501 cases and 2,063 deaths.
- Kyrgyzstan has 133,303 cases and 2,054 deaths as of July 6.
Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.
- As of July 7, Lebanon has 546,366 cases and 7,867 deaths.
- Lebanon has 545,965 cases and 7,865 deaths as of July 6.
- As of July 5, Lebanon has 545,671 cases and 7,863 deaths.
Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.
- Macau has 55 cases as of July 4.
- As of June 28, Macao has 54 cases.
- Macao has 52 cases as of June 10.
The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.
- As of July 7, the Maldives has 74,724 cases and 213 deaths.
- The Maldives has 74,585 cases and 213 deaths as of July 6.
- As of July 5, the Maldives has 74,480 cases and 213 deaths.
Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021.
- As of July 8, Mongolia has 131,962 cases and 655 deaths.
- As of July 7, Mongolia has 130,452 cases and 646 deaths.
- Mongolia has 128,454 cases and 639 deaths as of July 6.
Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.
- Nepal has 651,380 cases and 9,320 deaths as of July 8.
- As of July 7, Nepal has 650,162 cases and 9,291 deaths.
- Nepal has 648,085 cases and 9,263 deaths as of July 6.
North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.
- North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.
Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).
- As of July 8, Oman has 281,688 cases and 3,371 deaths.
- Oman has 280,235 cases and 3,356 deaths as of July 7.
- As of July 6, Oman has 278,560 cases and 3,339 deaths.
Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021.
- Pakistan has 967,633 cases and 22,493 deaths as of July 8.
- As of July 7, Pakistan has 966,007 cases and 22,469 deaths.
- Pakistan has 964,490 cases and 22,452 deaths as of July 6.
Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.
- As of July 7, Palestine has 314,869 cases and 3,577 deaths.
- Palestine has 314,780 cases and 3,576 deaths as of July 6.
- As of July 4, Palestine has 314,569 cases and 3,573 deaths.
Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021.
- As of July 7, Qatar has 222,918 cases and 596 deaths.
- Qatar has 222,760 cases and 594 deaths as of July 6.
- Qatar has 222,667 cases and 593 deaths as of July 5.
A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.
- Russia has 5,707,452 cases and 140,775 deaths as of July 8.
- As of July 7, Russia has 5,682,634 cases and 140,041 deaths.
- Our new Russia-specific updates here.
Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021.
- Saudi Arabia has 497,773 cases and 7,933 deaths as of July 8.
- As of July 7, Saudi Arabia has 496,516 cases and 7,921 deaths.
- Saudi Arabia has 495,309 cases and 7,907 deaths as of July 6.
South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021.
- As of July 8, South Korea has 164,028 cases and 2,034 deaths.
- South Korea has 162,753 cases and 2,033 deaths as of July 7.
- South Korea has 161,541 cases and 2,032 deaths as of July 6.
Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.
- As of July 7, Sri Lanka has 268,676 cases and 3,351 deaths.
- Sri Lanka has 267,433 cases and 3,313 deaths as of July 6.
- As of July 5, Sri Lanka has 266,499 cases and 3,268 deaths.
Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.
- Taiwan has 15,149 cases and 718 deaths as of July 8.
- As of July 7, Taiwan has 15,128 cases and 715 deaths.
- Taiwan has 15,088 cases and 706 deaths as of July 6.
Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.
- As of July 7, Turkey has 5,459,923 cases and 50,048 deaths.
- Turkey has 5,454,763 cases and 49,996 deaths as of July 6.
- Turkey has 5,449,464 cases and 49,959 deaths as of July 5.
United Arab Emirates
The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates. The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.
- As of July 7, the UAE has 644,114 cases and 1,847 deaths.
- The UAE has 642,601 cases and 1,843 deaths as of July 6.
- As of July 5, the UAE has 641,049 cases and 1,839 deaths.
Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021.
- As of July 7, Uzbekistan has 114,039 cases and 758 deaths.
- As of July 6, Uzbekistan has 113,568 cases and 754 deaths.
- Uzbekistan has 113,072 cases and 751 deaths as of July 5.
Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.
- Yemen has 6,934 cases and 1,364 deaths as of July 7.
- As of July 6, Yemen has 6,931 cases and 1,363 deaths.
- Yemen has 6,929 cases and 1,362 deaths as of July 5.
ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in Singapore, Hanoi, Ho Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at email@example.com or visit our website at www.dezshira.com.